UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypoxia Signaling in Cancer: From Basics to Clinical Practice

Pathology oncology research, 2021-05, Vol.27, p.1609802-1609802

2021

Volltextzugriff (PDF)

2‐acetylaminofluorene dose‐dependent differentiation of rat oval cells into hepatocytes: Confocal and electron microscopic studies

Hepatology (Baltimore, Md.), 2004-05, Vol.39 (5), p.1353-1361

2004

Volltextzugriff (PDF)

Editorial: Pathology and Oncology Research: addressing publication ethics issues

Pathology oncology research, 2024-02, Vol.30, p.1611691-1611691

2024

Volltextzugriff (PDF)

The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis

Pathology oncology research, 2020, Vol.26 (1), p.49-61

2020

Volltextzugriff (PDF)

Lapatinib: A Sword With Two Edges

Pathology oncology research, 2008-03, Vol.14 (1), p.1-8

Kopper, László

2008

Volltextzugriff (PDF)

Denosumab—A Powerful RANKL Inhibitor to Stop Lytic Metastases and Other Bone Loss Actions by Osteoclasts

Pathology oncology research, 2012-10, Vol.18 (4), p.743-747

Kopper, László

2012

Volltextzugriff (PDF)

Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone

Histopathology, 2011-09, Vol.59 (3), p.376-389

2011

Volltextzugriff (PDF)

mTOR activity and its prognostic significance in human colorectal carcinoma depending on C1 and C2 complex-related protein expression

Journal of clinical pathology, 2017-05, Vol.70 (5), p.410-416

2017

Volltextzugriff (PDF)

Expression of mTORC1/2-related proteins in primary and brain metastatic lung adenocarcinoma

Human pathology, 2017-04, Vol.62, p.66-73

2017

Volltextzugriff (PDF)

Integrating molecular diagnostics into anticancer drug discovery

Nature reviews. Drug discovery, 2010-07, Vol.9 (7), p.523-535

2010

Volltextzugriff (PDF)

Aberrant somatic hypermutation and expression of activation‐induced cytidine deaminase mRNA in mediastinal large B‐cell lymphoma

British journal of haematology, 2005-05, Vol.129 (3), p.373-376

2005

Volltextzugriff (PDF)

Expression of Certain Leukemia/Lymphoma Related microRNAs and its Correlation with Prognosis in Childhood Acute Lymphoblastic Leukemia

Pathology oncology research, 2015-07, Vol.21 (3), p.597-604

2015

Volltextzugriff (PDF)

Mammalian target of rapamycin (mTOR) activity dependent phospho-protein expression in childhood acute lymphoblastic leukemia (ALL)

PloS one, 2013-04, Vol.8 (4), p.e59335

2013

Volltextzugriff (PDF)

Different Ways to Induce Apoptosis by Fenretinide and All-trans-retinoic Acid in Human B Lymphoma Cells

Anticancer research, 2005-11, Vol.25 (6B), p.4179-4185

2005

Volltextzugriff (PDF)

Panitumumab: An Arrow on Target

Pathology oncology research, 2010-06, Vol.16 (2), p.143-148

Kopper, László

2010

Volltextzugriff (PDF)

The Effects of Different mTOR Inhibitors in EGFR Inhibitor Resistant Colon Carcinoma Cells

Pathology oncology research, 2019-10, Vol.25 (4), p.1379-1386

2019

Volltextzugriff (PDF)

Mevastatin-induced Apoptosis and Growth Suppression in U266 Myeloma Cells

Anticancer research, 2004-05, Vol.24 (3A), p.1817-1822

2004

Volltextzugriff (PDF)

Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement

Lung cancer (Amsterdam, Netherlands), 2014-01, Vol.83 (1), p.109-111

2014

Volltextzugriff (PDF)

Activity and complexes of mTOR in diffuse large B-cell lymphomas—a tissue microarray study

Modern pathology, 2012-12, Vol.25 (12), p.1623-1628

2012

Volltextzugriff (PDF)

Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo study

BMC cancer, 2013-05, Vol.13 (1), p.250-250, Article 250

2013

Volltextzugriff (PDF)

Rapamycin can restore the negative regulatory function of transforming growth factor beta 1 in high grade lymphomas

Cytokine (Philadelphia, Pa.), 2015-06, Vol.73 (2), p.219-224

2015

Volltextzugriff (PDF)

Immunohistochemical analysis of cytokeratin 7 expression in resting and proliferating biliary structures of rat liver

Hepatology (Baltimore, Md.), 2005-10, Vol.42 (4), p.863-870

2005

Volltextzugriff (PDF)

Centrosome abnormalities in giant cell tumour of bone: possible association with chromosomal instability

Modern pathology, 2010-03, Vol.23 (3), p.359-366

2010

Volltextzugriff (PDF)

Molecular Targeting of Cell Death Signal Transduction Pathways in Cancer

Current signal transduction therapy, 2006-01, Vol.1 (1), p.113-131

2006

Volltextzugriff (PDF)

Population Pharmacogenomics and Personalized Medicine Research in Hungary: Achievements and Lessons Learned

Current pharmacogenomics and personalized medicine, 2010-09, Vol.8 (3), p.194-201

2010

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(95)

Publikationsform

Artikel
(127)

Sprache

Englisch
(117)
Ungarisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypoxia Signaling in Cancer: From Basics to Clinical Practice

2‐acetylaminofluorene dose‐dependent differentiation of rat oval cells into hepatocytes: Confocal and electron microscopic studies

Editorial: Pathology and Oncology Research: addressing publication ethics issues

The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis

Lapatinib: A Sword With Two Edges

Denosumab—A Powerful RANKL Inhibitor to Stop Lytic Metastases and Other Bone Loss Actions by Osteoclasts

Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone

mTOR activity and its prognostic significance in human colorectal carcinoma depending on C1 and C2 complex-related protein expression

Expression of mTORC1/2-related proteins in primary and brain metastatic lung adenocarcinoma

Integrating molecular diagnostics into anticancer drug discovery

Aberrant somatic hypermutation and expression of activation‐induced cytidine deaminase mRNA in mediastinal large B‐cell lymphoma

Expression of Certain Leukemia/Lymphoma Related microRNAs and its Correlation with Prognosis in Childhood Acute Lymphoblastic Leukemia

Mammalian target of rapamycin (mTOR) activity dependent phospho-protein expression in childhood acute lymphoblastic leukemia (ALL)

Different Ways to Induce Apoptosis by Fenretinide and All-trans-retinoic Acid in Human B Lymphoma Cells

Panitumumab: An Arrow on Target

The Effects of Different mTOR Inhibitors in EGFR Inhibitor Resistant Colon Carcinoma Cells

Mevastatin-induced Apoptosis and Growth Suppression in U266 Myeloma Cells

Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement

Activity and complexes of mTOR in diffuse large B-cell lymphomas—a tissue microarray study

Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo study

Rapamycin can restore the negative regulatory function of transforming growth factor beta 1 in high grade lymphomas

Immunohistochemical analysis of cytokeratin 7 expression in resting and proliferating biliary structures of rat liver

Centrosome abnormalities in giant cell tumour of bone: possible association with chromosomal instability

Molecular Targeting of Cell Death Signal Transduction Pathways in Cancer

Population Pharmacogenomics and Personalized Medicine Research in Hungary: Achievements and Lessons Learned

Suchergebnisse filtern